Omeprazole Withdrawn Phase 2 Trials for NASH - Nonalcoholic Steatohepatitis / Type 2 Diabetes Mellitus / NAFLD Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03291249Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM